CRISPR/Cas9 mediated homology directed repair (HDR) was used to knock-in A1R under the control of the NR4A2 promoter, which we have previously shown to be highly effective in restricting transgene expression to the tumor site37. The gene discussed is NR4A2; the disease is neoplasm.